Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares What androgen deprivation costs: the side of hormone therapy the survival curves do not show, Metastasis-free survival (MFS), Other-cause mortality, TNM staging for prostate cancer, and what changed in the 9th edition and the tag subtype-page.
Shares PSA kinetics: PSA doubling time and PSA density, Other-cause mortality, TNM staging for prostate cancer, and what changed in the 9th edition, Biochemical recurrence of prostate cancer and the tag subtype-page.
Shares Other-cause mortality, TNM staging for prostate cancer, and what changed in the 9th edition, Report death from other causes as an outcome of the prostate cancer service, split by deprivation and ethnicity, Biochemical recurrence of prostate cancer and the tag subtype-page.
Shares PTEN loss and the tag subtype-page.
Shares PTEN loss and the tag subtype-page.
Shares PTEN loss and the tag subtype-page.
Shares TNM staging for prostate cancer, and what changed in the 9th edition, Neuroendocrine and small-cell prostate cancer, PSA (prostate-specific antigen), Metastatic hormone-sensitive prostate cancer and the tag subtype-page.
Shares Apalutamide, Bicalutamide, Enzalutamide, Androgen deprivation & AR pathway inhibitors and the tag subtype-page.
The same record for scripts and assistants; checked 2026-09-25. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.